India is stepping up efforts to combat cervical cancer, a disease linked to Human Papillomavirus (HPV) infections in the vast majority of cases. Reports suggest that the indigenous HPV vaccine Cervavac could become part of a larger national vaccination programme after 2027. Meanwhile, vaccine alliance Gavi is expected to supply 2.6 crore doses to support ongoing immunisation efforts. The move reflects India's growing focus on prevention, early intervention and reducing the burden of one of the country's most common cancers among women.


India Expands Cervical Cancer Fight as HPV Vaccine Push Grows 

India is set to roll out a nationwide HPV vaccination drive aimed at protecting adolescent girls from cervical cancer, with nearly one crore girls becoming eligible every year. The ambitious public health initiative is expected to significantly reduce cervical cancer cases and strengthen India’s preventive healthcare push.


HPV vaccination drive in India to begin soon, one crore girls to be eligible every year

<p>A new cervical cancer treatment that can cut the risk of death by 40 per cent in patients has been found, the most significant improvement in treating this type of cancer that affects millions of women.</p>

<p>Cervical cancer is the fourth most common cancer in women, according to the World Health Organization. It is caused by the human papillomavirus (HPV). &nbsp;</p>

<p>According to Cancer Research UK, which funded the research, the INTERLACE trial showed that a small course of chemotherapy before the standard chemoradiation treatment can reduce the risk of death by 40 per cent, and cut recurrence chances by 35 per cent.</p>

<p><strong>Watch: QUAD's 'Cancer Moonshot' Plan Explained: Initiative To Prevent Cervical Cancer</strong></p>

<div class="ui-state-default" contenteditable="false">
<div class="twitter-block" draggable="false">
<div class="videoWrapper trancodeVideo"><iframe allowfullscreen="" autoplay="1" class="includeVideo" frameborder="0" height="350" src="https://www.wionews.com/videos/quads-cancer-moonshot-plan-explained-initiative-to-prevent-cervical-cancer-760774/embed" style="width:100%;max-width:560px;" width="560"></iframe></div>
</div>
<a class="close-mark close-div" href="#" id="jqclosemark">×</a></div>

<p>Cervical cancer treatment currently involves chemoradiation, a combination of chemotherapy and radiotherapy.</p>

<p>The new findings indicate that six weeks of induction chemotherapy before CRT can improve survival rates, much before opting for surgery.</p>

<p>The treatment was given to a group of patients five years ago, and 80 per cent of them are still alive, said Cancer Research UK on its website. Among the test participants, the cancer did not come back for 73 per cent.</p>

<p>Dr Iain Foulkes from Cancer Research UK stressed that timing is important in treating cervical cancer. “The simple act of adding induction chemotherapy to the start of chemoradiation treatment for cervical cancer has delivered remarkable results in this trial.”&nbsp;</p>

<p><strong><a href="https://www.wionews.com/health-and-wellness/cervical-cancer-experts-tell-importance-of-symptoms-and-preventive-measures-a-must-read-for-all-women-683639">Also read: Cervical Cancer: Experts talk about preventive measures. A must-read for all women</a></strong></p>

<p>Two already approved chemotherapy medicines were used, which are affordable and easily available, which makes the test treatment significant.&nbsp;</p>

<p>“This is the biggest improvement in outcome in this disease in over 20 years,”&nbsp;Dr Mary McCormack, the lead investigator of the trial from University College London’s Cancer Institute and University College London Hospital said.</p>

<p>“I’m incredibly proud of all the patients who participated in the trial; their contribution has allowed us to gather the evidence needed to improve treatment of cervical cancer patients everywhere,” Cancer Research UK quoted her as saying.&nbsp;&nbsp;</p>

<p><strong><a href="https://www.wionews.com/entertainment/lifestyle/news-what-is-cervical-cancer-expert-answers-as-spotlight-turns-to-disease-after-poonam-pandeys-reported-death-686377">Also read: What is cervical cancer? Expert answers as spotlight turns to disease after Poonam Pandey's death stunt</a></strong><br />
<br />
&nbsp;As per data from WHO, 660,000 new cases of cervical cancer and 350,000 deaths were reported across the world in 2022.</p>

<p>Cervical cancer can be cured if diagnosed and treated at the early stages.</p>

<p>Cost-effective preventive strategies include prophylactic vaccination and screening and treatment of pre-cancer lesions.<br />
<br />
<em>(With inputs from agencies)</em></p>


A new cervical cancer treatment that can cut the risk of death by 40 per cent in patients has been found, the most significant improvement in treating this type of cancer that affects millions of women.

A new cervical cancer treatment that can cut the risk of death by 40 per cent in patients has been found, the most significant improvement in treating this type of cancer that affects millions of women. Cervical cancer is the fourth most common cancer in women, according to the World Health Organization. It is caused by the human papillomavirus (HPV). According to Cancer Research UK, which funded the research, the INTERLACE trial showed that a small course of chemotherapy before the standard chemoradiation treatment can reduce the risk of death by 40 per cent, and cut recurrence chances by 35 per cent. Watch: QUAD's 'Cancer Moonshot' Plan Explained: Initiative To Prevent Cervical Cancer × Cervical cancer treatment currently involves chemoradiation, a combination of chemotherapy and radiotherapy. The new findings indicate that six weeks of induction chemotherapy before CRT can improve survival rates, much before opting for surgery. The treatment was given to a group of patients five years ago, and 80 per cent of them are still alive, said Cancer Research UK on its website. Among the test participants, the cancer did not come back for 73 per cent. Dr Iain Foulkes from Cancer Research UK stressed that timing is important in treating cervical cancer. “The simple act of adding induction chemotherapy to the start of chemoradiation treatment for cervical cancer has delivered remarkable results in this trial.” Also read: Cervical Cancer: Experts talk about preventive measures. A must-read for all women Two already approved chemotherapy medicines were used, which are affordable and easily available, which makes the test treatment significant. “This is the biggest improvement in outcome in this disease in over 20 years,” Dr Mary McCormack, the lead investigator of the trial from University College London’s Cancer Institute and University College London Hospital said. “I’m incredibly proud of all the patients who participated in the trial; their contribution has allowed us to gather the evidence needed to improve treatment of cervical cancer patients everywhere,” Cancer Research UK quoted her as saying. Also read: What is cervical cancer? Expert answers as spotlight turns to disease after Poonam Pandey's death stunt As per data from WHO, 660,000 new cases of cervical cancer and 350,000 deaths were reported across the world in 2022. Cervical cancer can be cured if diagnosed and treated at the early stages. Cost-effective preventive strategies include prophylactic vaccination and screening and treatment of pre-cancer lesions. (With inputs from agencies)

Cervical cancer treatment breakthrough that can cut risk of death by 40 per cent found

Approximately 1 in 3 men worldwide carries a silent yet significant sexually transmitted infection, the HPV (Human Papillomavirus). Join us as we unveil the hidden truth behind this global health issue and shatter a major misconception – HPV is not just a women's concern.

Gravitas | HPV: The STI That Impacts 1 in 3 Men Worldwide | Hidden Truth Revealed

<p>Throat cancer cases in the West since the start of the twenty-first century have rapidly increased. The spike in throat cancer cases is significant enough that in the recent past, experts have called it "an epidemic".</p>

<p>The large rise in a type of throat cancer called oropharyngeal cancer (the area of the tonsils and back of the throat) has even alarmed medical experts. This type of cancer is majorly caused by human papillomavirus (HPV), which is sexually transmitted. Individuals with multiple sexual partners, who also practice oral sex, remain at the risk of acquiring this type of throat cancer during their lifetime, according to professor Hisham Mehanna at the Institute of Cancer and Genomic Sciences at the University of Birmingham.&nbsp;</p>

<p><strong>ALSO READ |&nbsp;<a href="https://www.wionews.com/world/historic-hpv-vaccine-lowers-cervical-cancer-rates-by-90-per-cent-says-uk-study-426638">'Historic': HPV vaccine lowers cervical cancer rates by 90 per cent, says UK study</a></strong></p>

<p>According to a 'case-control study of HPV and Oropharyngeal Cancer' published in the New England Journal of Medicine, individuals with six or more lifetime oral-sex partners are 8.5 times more likely to develop oropharyngeal cancer than those who do not practice oral sex.&nbsp;</p>

<p>Oropharyngeal cancer is now more common than cervical cancer in the United States and the United Kingdom.</p>

<p><strong>ALSO WATCH |&nbsp;Surge in sexually transmitted diseases in US</strong></p>

<div class="ui-state-default" contenteditable="false">
<div class="twitter-block" draggable="false">
<div class="videoWrapper trancodeVideo"><iframe allowfullscreen="" autoplay="1" class="includeVideo" frameborder="0" height="350" src="https://www.wionews.com/videos/surge-in-sexually-transmitted-diseases-in-us-518187/embed" style="width:100%;max-width:560px;" width="560"></iframe></div>
</div>
<a class="close-mark close-div" href="#" id="jqclosemark">×</a></div>

<p>Professor Mehanna cited a study he and his colleagues at the University of Birmingham conducted. The study showed that oral sex is quite prevalent in some countries. In almost 1,000 people with non-cancer related tonsillectomy issues in the United Kingdom, 80 per cent of adults reported practicing oral sex at some point in their lives.&nbsp;</p>

<h2><strong>HPV vaccination a preventive step</strong></h2>

<p>An article by professor Hisham Mehanna in The Conversation points out that HPV vaccination of young girls has been implemented in a number of countries to prevent cervical cancer. In the countries with up to 85 per cent vaccine coverage among girls, boy are protected by human papillomavirus (HPV) due to herd immunity.&nbsp;</p>

<p>But still, internationally, the vaccination does not warrant individual protection in an age of hyperconnectivity where plenty of sexual contacts may occur where the either person comes from a country with low HPV vaccine coverage.&nbsp;</p>

<p>In India, Prime Minister Narendra Modi's government in February 2023 announced plans to administer HPV vaccine to girls aged nine to 14 years in six states.</p>

<p>This first phase of the HPV vaccination campaign is expected to target 255 million girls in Karnataka, Tamil Nadu, Mizoram, Chhattisgarh, Maharashtra, and Uttar Pradesh states respectively, Press Trust of India reported. India's health ministry plans to acquire 160.2 million doses of the vaccine by 2026 and is preparing to tender a global call for bids.</p>

<p><strong>WATCH WION LIVE HERE</strong></p>

<p><iframe allow="accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture" allowfullscreen="" frameborder="0" height="350" loading="”lazy”" src="https://www.wionews.com/live-tv/embed?autoplay=1&amp;mute=1  width=&quot;100%&quot;"></iframe></p>

<p>You can <strong>now write for wionews.com</strong> and be a part of the community. Share your stories and opinions with us <strong><a href="https://www.wionews.com/content-contribution-registration-form">here</a>.</strong></p>


Throat cancer cases in the West since the start of the twenty-first century have rapidly increased. The spike in throat cancer cases is significant enough that in the recent past, experts have called it "an epidemic".

Throat cancer cases in the West since the start of the twenty-first century have rapidly increased. The spike in throat cancer cases is significant enough that in the recent past, experts have called it "an epidemic". The large rise in a type of throat cancer called oropharyngeal cancer (the area of the tonsils and back of the throat) has even alarmed medical experts. This type of cancer is majorly caused by human papillomavirus (HPV), which is sexually transmitted. Individuals with multiple sexual partners, who also practice oral sex, remain at the risk of acquiring this type of throat cancer during their lifetime, according to professor Hisham Mehanna at the Institute of Cancer and Genomic Sciences at the University of Birmingham. ALSO READ | 'Historic': HPV vaccine lowers cervical cancer rates by 90 per cent, says UK study According to a 'case-control study of HPV and Oropharyngeal Cancer' published in the New England Journal of Medicine, individuals with six or more lifetime oral-sex partners are 8.5 times more likely to develop oropharyngeal cancer than those who do not practice oral sex. Oropharyngeal cancer is now more common than cervical cancer in the United States and the United Kingdom. ALSO WATCH | Surge in sexually transmitted diseases in US × Professor Mehanna cited a study he and his colleagues at the University of Birmingham conducted. The study showed that oral sex is quite prevalent in some countries. In almost 1,000 people with non-cancer related tonsillectomy issues in the United Kingdom, 80 per cent of adults reported practicing oral sex at some point in their lives. HPV vaccination a preventive step An article by professor Hisham Mehanna in The Conversation points out that HPV vaccination of young girls has been implemented in a number of countries to prevent cervical cancer. In the countries with up to 85 per cent vaccine coverage among girls, boy are protected by human papillomavirus (HPV) due to herd immunity. But still, internationally, the vaccination does not warrant individual protection in an age of hyperconnectivity where plenty of sexual contacts may occur where the either person comes from a country with low HPV vaccine coverage. In India, Prime Minister Narendra Modi's government in February 2023 announced plans to administer HPV vaccine to girls aged nine to 14 years in six states. This first phase of the HPV vaccination campaign is expected to target 255 million girls in Karnataka, Tamil Nadu, Mizoram, Chhattisgarh, Maharashtra, and Uttar Pradesh states respectively, Press Trust of India reported. India's health ministry plans to acquire 160.2 million doses of the vaccine by 2026 and is preparing to tender a global call for bids. WATCH WION LIVE HERE You can now write for wionews.com and be a part of the community. Share your stories and opinions with us here.

Oral sex emerges as major risk factor for throat cancer, claims study

Hpv, News on Hpv, stories on Hpv, articles on Hpv, Hpv stories at Wion, Hpv news, Hpv latest news